In a recent article, investigators describe multiple cases of organ transplant derived Ehrlichiosis infections in donor recipients. Two cases of ehrlichiosis were reported to the Organ Procurement and Transplantation Network (OPTN) and the Centers for Disease Control and Prevention (CDC) for investigation in 2020. These two kidney recipients from a common donor developed fatal ehrlichiosis-induced […]
Ohio State University researchers have just published on their creation of nanobodies which target the protein that causes E. chaffeensis bacteria to be extremely infectious. It is thought that these nanobodies can be developed as a new or complementary therapy for human monocytic ehrlichiosis as well as other tick-borne diseases that are caused by intracellular infections, infections that can be fatal if left untreated or undertreated.
Scientists used to separate ehrlichiosis into two entities caused by the bacterium Ehrlichia: Human Monocytic Ehrlichiosis (HME) and Human Granulocytic Ehrlichiosis (HGE). After further study, they determined that HGE is actually caused by a bacterium, Anaplasma phagacytophilum. HME is caused by a bacterium, Ehrlichia chaffeensis. Symptoms of ehrlichiosis/anaplasmosis include: fever, malaise, headaches, chills, severe muscle aches, vomiting, […]